Actively Recruiting
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Led by Boston Children's Hospital · Updated on 2025-03-03
50
Participants Needed
1
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators will be administering oral high dose interval vitamin D, concurrently when participants are receiving biologic therapy for their inflammatory bowel disease. The investigators will be collecting some additional bloodwork and questionnaires at the time of participants infusions.
CONDITIONS
Official Title
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Existing diagnosis of inflammatory bowel disease, including Crohn disease, ulcerative colitis, or indeterminate colitis
- Receiving treatment with Infliximab or Vedolizumab every 4 to 8 weeks
- Age between 5 and 25 years at study entry
- Serum 25-hydroxyvitamin D level less than 40 ng/mL measured within the last 4 to 8 weeks with no changes in vitamin D supplementation during that time
You will not qualify if you...
- History of any kidney disease
- History of preexisting liver disease
- History of granulomatous disease
- Unable to take oral vitamin D3 as a pill
- History of hypercalcemia or hypercalciuria
- Currently or within the past 3 months taking anti-epileptic medication or Lasix
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
R
Rebecca Gordon, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here